Merck settles state Vioxx probes, to pay $58 million
NEW YORK (Reuters) - Merck & Co Inc said on Tuesday it will pay $58 million to settle state investigations into its withdrawn pain drug Vioxx.
<p><img src="http://feeds.reuters.com/~a/reuters/businessNews?i=5IV2bS" border="0"></img> (http://feeds.reuters.com/~a/reuters/businessNews?a=5IV2bS)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/businessNews?i=CUIQRH" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=CUIQRH) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=KJtRJh" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=KJtRJh) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=roGL2h" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=roGL2h)
</div><img src="http://feeds.reuters.com/~r/reuters/businessNews/~4/294414769" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/294414769/idUSWNAS477020080520